FOLH1 and posterior cortical atrophy: For instance, studies have shown that PSMA‐targeted nanoparticles improve intracellular drug accumulation in PCa cells compared with non‐targeted systems, highlighting their role in overcoming traditional delivery barriers [37, 38].